Forian Inc. (NASDAQ:FORA) Reports Significant Decrease in Short Interest for November

Forian Inc. (NASDAQ:FORA) experienced a notable reduction in its short interest throughout November. By November 30th, the total short interest was recorded at 132,400 shares, marking an 11.3% decrease from the 149,200 shares reported on November 15th. This reduction indicates that approximately 1.0% of the company's total shares are currently sold short. Given that the average trading volume stands at 17,100 shares, the days-to-cover ratio is calculated to be 7.7 days.

Analyst Insights on Forian Inc.

In related news, Roth MKM reaffirmed their "buy" rating for Forian's stocks and established a price target of $5.00 in a report published on November 14th.

Changes in Institutional Investor Positions

Multiple institutional investors and hedge funds have altered their investments in Forian Inc. recently. Elser Financial Planning Inc initiated a new position in Forian during the second quarter, amounting to approximately $1,885,000. Caprock Group LLC also entered a new investment in the second quarter, valued at around $230,000. Additionally, Canton Hathaway LLC increased its holdings in Forian by 2.3% during the third quarter, now owning 269,650 shares worth $582,000 following the acquisition of an extra 6,125 shares in the most recent quarter. The collective stake held by institutional investors and hedge funds in Forian is approximately 19.25% of the total shares.

Current Stock Performance of Forian

On Tuesday, Forian's stock (NASDAQ:FORA) saw an increase of 2.0%, rising by $0.04 to reach a price of $2.04. The trading volume for the day was 18,522 shares, exceeding the average volume of 16,417. Over the past year, Forian's stock has fluctuated between a low of $1.97 and a high of $4.15. The company has a market cap of $63.27 million, with a price-to-earnings ratio of -22.22 and a beta of 1.07. The fifty-day simple moving average is $2.07, while the two-hundred-day moving average stands at $2.33.

Company Overview of Forian Inc.

Forian Inc. specializes in providing comprehensive data management services, along with information and analytical solutions designed to optimize and assess operational, clinical, and financial performance for clients in the healthcare and allied industries. The company develops real-world evidence (RWE), market access solutions, and delivers unique data-driven insights while also offering data management services.

Further Reading Opportunities

• Five Stocks Better Than Forian
• Insights into Investing in Oil Stocks
• Sales Insights from AppLovin Insiders
• Guide to Investing in Canadian Stocks
• Broadcom's Positive Outlook
• Understanding Penny Stock Investments
• Salesforce's Path Forward

Forian, shortinterest, stocks